INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.855
+0.065 (3.63%)
Jul 10, 2026, 11:15 AM EDT - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $49.32 million as of July 10, 2026. Its market cap has decreased by -71.17% in one year.
Market Cap
49.32M
Enterprise Value
27.74M
1-Year Change
-71.17%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $49.32M, a decrease of -36.63%. That is a compound annual growth rate of -5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 49.32M | 18.91% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 47.48M |
| Metagenomi Therapeutics | 47.44M |
| Dogwood Therapeutics | 47.42M |
| Hyperion DeFi | 46.38M |
| Veru Inc. | 45.10M |
| Eloxx Pharmaceuticals | 44.40M |
| PDS Biotechnology | 43.70M |
| Aligos Therapeutics | 42.39M |